Regulation of vascular morphogenesis by the matricellular protein SPARC. (Q41469686)

1 October 2017

1 reference

title

Regulation of vascular morphogenesis by the matricellular protein SPARC. (English)

1 reference

1 October 2017

1 reference

Motamed K

1

1 reference

PubMed ID

9150448

1 October 2017

Sage EH

series ordinal

2

1 reference

PubMed ID

9150448

1 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

1 October 2017

1 reference

1 October 2017

51

1 reference

1 October 2017

5

1 reference

1 October 2017

1383-1387

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1997.189

1 October 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

The implications of angiogenesis for the biology and therapy of cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Mechanisms of Endothelial Growth Control

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells--implications for the modulation of FGF-2.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1997.189

1 reference

7 January 2021

The biology of SPARC, a protein that modulates cell-matrix interactions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

SPARC is a source of copper-binding peptides that stimulate angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Distribution of osteonectin mRNA and protein during human embryonic and fetal development

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

The Caenorhabditis elegans homologue of the extracellular calcium binding protein SPARC/osteonectin affects nematode body morphology and mobility

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.189

7 January 2021

Identifiers

DOI

10.1038/KI.1997.189

1 reference

1 October 2017

1 reference

PubMed ID

9150448